• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Glucose Monitor Diamontech Receives ISO

Share:

April 29, 2021

German Medtech startup DiaMonTech has received the official certification for medical device manufacturers from the International Organisation for Standardisation (ISO) for its non-invasive blood glucose measurement tool.

ISO 13485 is designed to help medical device companies demonstrate safe and ethical design and development. To receive certification, organizations must demonstrate that their Quality Management Systems deliver medical devices that consistently meet customer and regulatory requirements.

The certification is considered to be the initial step for DiaMonTech to qualify for the Medical Device Directive (MDD) process in the European Union and paves the way for further development in the startup’s plans to deliver handheld and wearable health monitoring devices.

Source: Mobihealthnews

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Miltenyi Biotec Acquires Biosensor Company Lino BiotechMiltenyi Biotec Acquires Biosensor Company Lino Biotech
  • Redpin Therapeutics Secures Initial Closing of $15.5 Million in Series A FinancingRedpin Therapeutics Secures Initial Closing of $15.5 Million in Series A Financing
  • What’s AI’s Holdup in Healthcare? The Answer Is In The CloudWhat’s AI’s Holdup in Healthcare? The Answer Is In The Cloud
  • Epic Pharmacy Progress Made But Gaps Remain, KLAS Report FindsEpic Pharmacy Progress Made But Gaps Remain, KLAS Report Finds
  • Crown Laboratories Acquires Xycrobe™ Therapeutics, Inc., an Innovator in Skin Microbiome TechnologyCrown Laboratories Acquires Xycrobe™ Therapeutics, Inc., an Innovator in Skin Microbiome Technology
  • Tauriga Sciences, Inc. Approved By Dutch Retail Conglomerate Ahold Delhaize to Become a Direct SupplierTauriga Sciences, Inc. Approved By Dutch Retail Conglomerate Ahold Delhaize to Become a Direct Supplier
  • Laborie Medical Technologies Inc. and Signet Healthcare Partners Close GI Supply AcquisitionLaborie Medical Technologies Inc. and Signet Healthcare Partners Close GI Supply Acquisition
  • Daily Foot Temperature Monitoring Leads to Fewer Hospitalizations, Amputations and MoreDaily Foot Temperature Monitoring Leads to Fewer Hospitalizations, Amputations and More

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications